Pharmacological Properties of Four Plant Species of the Genus Anabasis, Amaranthaceae

Molecules. 2023 May 31;28(11):4454. doi: 10.3390/molecules28114454.

Abstract

The genus Anabasis is a member of the family Amaranthaceae (former name: Chenopodiaceae) and includes approximately 102 genera and 1400 species. The genus Anabasis is one of the most significant families in salt marshes, semi-deserts, and other harsh environments. They are also renowned for their abundance in bioactive compounds, including sesquiterpenes, diterpenes, triterpenes, saponins, phenolic acids, flavonoids, and betalain pigments. Since ancient times, these plants have been used to treat various diseases of the gastrointestinal tract, diabetes, hypertension, and cardiovascular diseases and are used as an antirheumatic and diuretic. At the same time, the genus Anabasis is very rich in biologically active secondary metabolites that exhibit great pharmacological properties such as antioxidant, antibacterial, antiangiogenic, antiulcer, hypoglycemic, hepatoprotective, antidiabetic, etc. All of the listed pharmacological activities have been studied in practice by scientists from different countries and are presented in this review article to familiarize the entire scientific community with the results of these studies, as well as to explore the possibilities of using four plant species of the genus Anabasis as medicinal raw materials and developing medicines based on them.

Keywords: Amaranthaceae; Anabasis; antioxidant; pharmacological properties; traditional use.

Publication types

  • Review

MeSH terms

  • Amaranthaceae*
  • Chenopodiaceae* / microbiology
  • Ethnopharmacology
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Phytochemicals / pharmacology
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use

Substances

  • Hypoglycemic Agents
  • Plant Extracts
  • Phytochemicals

Grants and funding

This research received no external funding.